149 related articles for article (PubMed ID: 36137220)
1. PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer.
Zhang H; Li C; Liao S; Tu Y; Sun S; Yao F; Li Z; Wang Z
Cancer Biol Ther; 2022 Dec; 23(1):1-11. PubMed ID: 36137220
[TBL] [Abstract][Full Text] [Related]
2. Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma.
Li Q; Qiu J; Yang H; Sun G; Hu Y; Zhu D; Deng Z; Wang X; Tang J; Jiang R
Cancer Lett; 2020 Jul; 482():112-125. PubMed ID: 31733289
[TBL] [Abstract][Full Text] [Related]
3. PSMD12 promotes glioma progression by upregulating the expression of Nrf2.
Wang Z; Li Z; Xu H; Liao Y; Sun C; Chen Y; Sheng M; Lan Q; Wang Z
Ann Transl Med; 2021 Apr; 9(8):700. PubMed ID: 33987398
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of KIF15 inhibits the tumorigenesis of non-small-cell lung cancer via inactivating Raf/MEK/ERK signaling.
Luo Y; Zhang B; Xu L; Li M; Wu J; Zhou Y; Li Y
Histol Histopathol; 2022 Mar; 37(3):269-285. PubMed ID: 34908156
[TBL] [Abstract][Full Text] [Related]
5. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R
J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919
[TBL] [Abstract][Full Text] [Related]
6. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
[TBL] [Abstract][Full Text] [Related]
7. PSMD12 promotes non-small cell lung cancer progression through activating the Nrf2/TrxR1 pathway.
Lv J; Ma S; Wang X; Dang J; Ma F
Genes Genomics; 2024 Mar; 46(3):263-277. PubMed ID: 38243044
[TBL] [Abstract][Full Text] [Related]
8. KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway.
Wang J; Guo X; Xie C; Jiang J
Br J Cancer; 2017 Jul; 117(2):245-255. PubMed ID: 28595260
[TBL] [Abstract][Full Text] [Related]
9. PSMD12 interacts with CDKN3 and facilitates pancreatic cancer progression.
Ma J; Zhou W; Yuan Y; Wang B; Meng X
Cancer Gene Ther; 2023 Aug; 30(8):1072-1083. PubMed ID: 37037907
[TBL] [Abstract][Full Text] [Related]
10. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
11. Kinesin 12 (KIF15) contributes to the development and tumorigenicity of prostate cancer.
Qureshi Z; Ahmad M; Yang WX; Tan FQ
Biochem Biophys Res Commun; 2021 Oct; 576():7-14. PubMed ID: 34474246
[TBL] [Abstract][Full Text] [Related]
12. RNF173 suppresses RAF/MEK/ERK signaling to regulate invasion and metastasis via GRB2 ubiquitination in Hepatocellular Carcinoma.
Zhou J; Tu D; Peng R; Tang Y; Deng Q; Su B; Wang S; Tang H; Jin S; Jiang G; Wang Q; Jin X; Zhang C; Cao J; Bai D
Cell Commun Signal; 2023 Aug; 21(1):224. PubMed ID: 37626338
[TBL] [Abstract][Full Text] [Related]
13. PSMD12 promotes breast cancer growth via inhibiting the expression of pro-apoptotic genes.
Du X; Shen X; Dai L; Bi F; Zhang H; Lu C
Biochem Biophys Res Commun; 2020 May; 526(2):368-374. PubMed ID: 32222279
[TBL] [Abstract][Full Text] [Related]
14. DEAD-box Helicase 27 Promotes Hepatocellular Carcinoma Progression Through ERK Signaling.
Xiaoqian W; Bing Z; Yangwei L; Yafei Z; Tingting Z; Yi W; Qingjun L; Suxia L; Ling Z; Bo W; Peng Z
Technol Cancer Res Treat; 2021; 20():15330338211055953. PubMed ID: 34855554
[No Abstract] [Full Text] [Related]
15. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
Xie YX; Liao R; Pan L; Du CY
Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
[TBL] [Abstract][Full Text] [Related]
16. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
[TBL] [Abstract][Full Text] [Related]
17. KIF15 upregulation promotes leiomyosarcoma cell growth via promoting USP15-mediated DEK deubiquitylation.
Ge W; Chen Y; Guo Y; Zhao D; Mu L; Zhang K; Zhuo W
Biochem Biophys Res Commun; 2021 Sep; 570():117-124. PubMed ID: 34280614
[TBL] [Abstract][Full Text] [Related]
18. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
19. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
[No Abstract] [Full Text] [Related]
20. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]